secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-06-10T20:59:15+00:00
Accession:  0001493152-26-028129
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech amends bylaws: majority of votes cast standard for non-director proposals
--------------------------------------------------------------------------------

- Board approved Amendment to Bylaws effective June 9, 2026, changing voting standard for proposals other than director elections.
- New standard: affirmative vote of majority of votes cast (for/against only), excluding abstentions and broker non-votes.
- Previous standard required majority of shares present or by proxy and entitled to vote.
- Amendment filed as Exhibit 3.1 and incorporated by reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226028129/0001493152-26-028129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226028129/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer